Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Buteau · SciRah

Researcher profile · Semantic Scholar

J. Buteau

Share profile

J. Buteau — researcher profile on SciRah

h-index: 18
Works: 84
Citations: 1,867

Most-cited papers

The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
L. Emmett, J. Buteau, N. Papa, D. Moon +28 more
2021European Urology402 citations
Semantic Scholar
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.
J. Buteau, A. Martin, L. Emmett, A. Iravani +12 more
2022The Lancet Oncology226 citations Open access
Semantic Scholar
The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis
L. Emmett, N. Papa, J. Buteau, B. Ho +11 more
2022Journal of Nuclear Medicine220 citations Open access
Semantic Scholar
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
M. Hofman, L. Emmett, S. Sandhu, A. Iravani +27 more
2023The Lancet Oncology147 citations
Semantic Scholar
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.
R. Eapen, J. Buteau, P. Jackson, Catherine Mitchell +20 more
2023European Urology80 citations
Semantic Scholar
The Value of PET in Mild Cognitive Impairment, Typical and Atypical/Unclear Dementias: A Retrospective Memory Clinic Study
R. Laforce, J. Buteau, N. Paquet, L. Verret +2 more
2010American Journal of Alzheimers Disease & Other Dementias53 citations Open access
Semantic Scholar
First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study.
J. Buteau, Louise Kostos, P. Jackson, Jing Xie +26 more
2025The Lancet Oncology51 citations
Semantic Scholar
Radiation Dosimetry in 177Lu-PSMA-617 Therapy.
P. Jackson, M. Hofman, Lachlan McIntosh, J. Buteau +1 more
2021Seminars in nuclear medicine51 citations
Semantic Scholar
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)
Louise Kostos, J. Buteau, T. Yeung, J. Di Iulio +10 more
2022Frontiers in Medicine48 citations Open access
Semantic Scholar
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Edmond M. Kwan, Sarah W. S. Ng, S. Tolmeijer, L. Emmett +72 more
2025Nature Medicine44 citations
Semantic Scholar
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T
J. Buteau, Louise Kostos, R. Alipour, P. Jackson +15 more
2024Journal of Nuclear Medicine29 citations Open access
Semantic Scholar
Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer
Louise Kostos, J. Buteau, M. Hofman, A. Azad
2023Therapeutic Advances in Medical Oncology25 citations Open access
Semantic Scholar
Prostate‐specific membrane antigen theranostics in advanced prostate cancer: an evolving option
N. Mayor, N. Sathianathen, J. Buteau, S. Koschel +5 more
2020BJU International25 citations Open access
Semantic Scholar
Cognitive Impairment in ARCA-1, a Newly Discovered Pure Cerebellar Ataxia Syndrome
R. Laforce, J. Buteau, J. Bouchard, G. Rouleau +2 more
2010Cerebellum25 citations
Semantic Scholar
The role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer.
D. Bagguley, S. Ong, J. Buteau, S. Koschel +5 more
2021Future Oncology22 citations
Semantic Scholar
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically
L. Emmett, Nathan Papa, Thomas A. Hope, W. Fendler +28 more
2024Journal of Urology20 citations Open access
Semantic Scholar
Is 161Tb Really Happening?
Grace Kong, J. Buteau, Michael S. Hofman
2024Journal of Nuclear Medicine20 citations Open access
Semantic Scholar
Therapy-Related Myeloid Neoplasms After [177Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
M. Eifer, Duncan E. K. Sutherland, Isaac Goncalves, J. Buteau +12 more
2025Journal of Nuclear Medicine18 citations Open access
Semantic Scholar
Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials
Raghava Kashyap, J. Buteau, M. Bressel, M. Eifer +5 more
2025Journal of Nuclear Medicine18 citations Open access
Semantic Scholar
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial.
M. Hofman, V. Kasivisvanathan, E. Link, J. Buteau +22 more
2024European Urology Oncology18 citations Open access
Semantic Scholar
Quantitative calibration of Tb-161 SPECT/CT in view of personalised dosimetry assessment studies
Lachlan McIntosh, P. Jackson, B. Emmerson, J. Buteau +3 more
2024EJNMMI Physics18 citations Open access
Semantic Scholar
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer
Gideon Ptasznik, N. Papa, B. Kelly, James E. Thompson +7 more
2022BJU International18 citations Open access
Semantic Scholar
PSMA PET and FDG PET as predictors of response and prognosis in a randomized phase 2 trial of 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic, castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603).
J. Buteau, A. Martin, L. Emmett, A. Iravani +11 more
2022Journal of Clinical Oncology17 citations
Semantic Scholar
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, J. Buteau, Grace Kong, B. Tran +6 more
2025Journal of Nuclear Medicine16 citations Open access
Semantic Scholar
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review
Duncan E. K. Sutherland, R. Kashyap, P. Jackson, J. Buteau +8 more
2023Therapeutic Advances in Medical Oncology15 citations Open access
Semantic Scholar
VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T.
J. Buteau, Louise Kostos, R. Alipour, P. Jackson +16 more
2023Journal of Clinical Oncology14 citations
Semantic Scholar
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial.
Louise Kostos, J. Buteau, Jing Xie, A. Cardin +22 more
2025The Lancet Oncology13 citations
Semantic Scholar
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial.
A. Gafita, A. Martin, L. Emmett, M. Eiber +9 more
2024European Urology Oncology13 citations
Semantic Scholar
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
B. Kelly, Gideon Ptasznik, M. Roberts, Paul Doan +13 more
2023European Urology Open Science12 citations Open access
Semantic Scholar
LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [177Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Louise Kostos, J. Buteau, G. Kong, T. Yeung +6 more
2023Journal of Clinical Oncology11 citations Open access
Semantic Scholar
A Systematic Review of the Variability in Performing and Reporting Intraprostatic Prostate-specific Membrane Antigen Positron Emission Tomography in Primary Staging Studies.
Gideon Ptasznik, D. Moon, J. Buteau, B. Kelly +4 more
2023European Urology Open Science11 citations Open access
Semantic Scholar
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.
S. Sandhu, A. Joshua, L. Emmett, M. Bressel +26 more
2026The Lancet Oncology10 citations Open access
Semantic Scholar
Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617.
Heidi Fettke, Louise Kostos, Maria M. Docanto, P. Bukczynska +11 more
2025European Urology10 citations Open access
Semantic Scholar
1608P Prostate cancer working group 4 (PCWG4) preliminary criteria using serial PSMA PET/CT for response evaluation: Analysis from the PRINCE trial
M. Hofman, A. Gafita, M. Bressel, R. Alipour +13 more
2024Annals of Oncology10 citations
Semantic Scholar
Prognostic Value of Initial Imaging and PSA Change with [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
David C Chen, J. Buteau, Nathan Papa, T. Akhurst +19 more
2025Journal of Nuclear Medicine8 citations
Semantic Scholar
First-in-human results of terbium-161[ 161 Tb]Tb-PSMA-I&T radioligand treatment in patients with metastatic castration-resistant prostate cancer (VIOLET): A single-centre, single-arm, phase I/II study.
J. Buteau, Louise Kostos, P. Jackson, Lachlan McIntosh +16 more
2025Journal of Clinical Oncology8 citations
Semantic Scholar
Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer
Jonathan S. O'Brien, Aoife McVey, Brian Kelly, P. Jenjitranant +7 more
2022BJU International8 citations
Semantic Scholar
68Ga-DOTATATE Uptake in Ischemic Stroke.
É. Vallée, N. Paquet, J. Buteau, É. Turcotte
2018Clinical Nuclear Medicine8 citations
Semantic Scholar
Clonal hematopoiesis after 177Lu-PSMA-617 radioligand therapy in prostate cancer.
Aslı D. Munzur, C. Herberts, Edmond M. Kwan, L. Emmett +21 more
2026Clinical Cancer Research7 citations
Semantic Scholar
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study
David C Chen, J. Buteau, L. Emmett, R. Alipour +9 more
2025Journal of Nuclear Medicine7 citations Open access
Semantic Scholar
Deep Learning for Automated Measures of SUV and Molecular Tumor Volume in [68Ga]PSMA-11 or [18F]DCFPyL, [18F]FDG, and [177Lu]Lu-PSMA-617 Imaging with Global Threshold Regional Consensus Network
P. Jackson, J. Buteau, Lachlan McIntosh, Yu Sun +12 more
2025Journal of Nuclear Medicine7 citations Open access
Semantic Scholar
18F-FDG PET/CT uptake of a nonbacterial thrombotic endocarditis
J. Buteau, Jacques Morais, K. V. Keu
2016Journal of Nuclear Cardiology7 citations
Semantic Scholar
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
C. Udovicich, M. Bressel, J. Manji, Muhammad Ali +16 more
2025Journal of Nuclear Medicine6 citations Open access
Semantic Scholar
2391P LuPARP: Phase I trial of [177Lu]Lu-PSMA-617 (LuPSMA) and olaparib in patients (pts) with metastatic castration resistant prostate cancer (mCRPC)
S. Sandhu, A. Joshua, L. Emmett, M. Crumbaker +16 more
2025Annals of Oncology6 citations Open access
Semantic Scholar
Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate cancer
Narjess Ayati, Lachlan McIntosh, J. Buteau, R. Alipour +4 more
2024Cancer Imaging6 citations Open access
Semantic Scholar
Comparison of dual-energy CT with positron emission tomography for lung perfusion imaging in patients with non-small cell lung cancer
M. Gaudreault, J. Korte, N. Bucknell, P. Jackson +9 more
2023Physics in Medicine and Biology6 citations
Semantic Scholar
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer
Paul Doan, W. Counter, N. Papa, G. Sheehan-Dare +13 more
2022BJU International6 citations
Semantic Scholar
Circulating tumour DNA fraction as a predictor of treatment efficacy in a randomized phase 2 trial of [177Lu]Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603).
Edmond M. Kwan, M. Hofman, Sarah W. S. Ng, L. Emmett +16 more
2024Journal of Clinical Oncology5 citations Open access
Semantic Scholar
The evolving definition of bulky disease for lymphoma
J. Buteau, J. Seymour, M. Hofman
2020Leukemia and Lymphoma5 citations
Semantic Scholar
Re: 18F-Fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in Patients with Early Biochemical Recurrence After Prostatectomy: A Prospective, Single-centre, Single-arm, Comparative Imaging Trial.
S. Koschel, Jada Kapoosr, J. Buteau, D. Murphy
2019European Urology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Hofman×19
Invite
M. Hofman — researcher profile on SciRah
L. Emmett×18
Invite
L. Emmett — researcher profile on SciRah
M. Hofman×18
Invite
M. Hofman — researcher profile on SciRah
P. Jackson×14
Invite
P. Jackson — researcher profile on SciRah

×12

Invite

Louise Kostos — researcher profile on SciRah

Invite

R. Alipour — researcher profile on SciRah

Invite

A. Azad — researcher profile on SciRah

Lachlan McIntosh×11

Invite

Lachlan McIntosh — researcher profile on SciRah

Invite

Grace Kong — researcher profile on SciRah

A. Ravi Kumar×11

Invite

A. Ravi Kumar — researcher profile on SciRah

Invite

S. Sandhu — researcher profile on SciRah

Invite

A. Iravani — researcher profile on SciRah